Literature DB >> 16816954

[Therapy of atopic dermatitis].

C Abels1, E Proksch.   

Abstract

Atopic eczema is one of the most common diseases in dermatology. Patients suffer from both the chronic relapsing skin disease and the associated emotional stress. Itching and visible lesions on the face and hands are the most unpleasant features for many often young patients, seriously reducing their quality of life. New therapeutic approaches have changed the management of atopic eczema in recent years. Relatively potent new drugs with fewer side effects than corticosteroids help to control the disease. This review focuses on the basic principles of modern atopic eczema treatment, emphasizing basic emollient therapy and topical therapy with calcineurin inhibitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16816954     DOI: 10.1007/s00105-006-1176-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  35 in total

1.  The skin as a target for allergic diseases.

Authors:  N Novak; T Bieber
Journal:  Allergy       Date:  2000-02       Impact factor: 13.146

2.  Skin barrier function and allergic risk.

Authors:  Thomas J Hudson
Journal:  Nat Genet       Date:  2006-04       Impact factor: 38.330

Review 3.  Clinical practice. Atopic dermatitis.

Authors:  Hywel C Williams
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

4.  Topical treatment by urea reduces epidermal hyperproliferation and induces differentiation in psoriasis.

Authors:  I Hagemann; E Proksch
Journal:  Acta Derm Venereol       Date:  1996-09       Impact factor: 4.437

Review 5.  Essential fatty acid metabolism and its modification in atopic eczema.

Authors:  D F Horrobin
Journal:  Am J Clin Nutr       Date:  2000-01       Impact factor: 7.045

Review 6.  Skin barrier dysfunction and systemic sensitization to allergens through the skin.

Authors:  Jessica Strid; Stephan Strobel
Journal:  Curr Drug Targets Inflamm Allergy       Date:  2005-10

7.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis.

Authors:  Peck Y Ong; Takaaki Ohtake; Corinne Brandt; Ian Strickland; Mark Boguniewicz; Tomas Ganz; Richard L Gallo; Donald Y M Leung
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

8.  Linkage between atopy and the IgE high-affinity receptor gene at 11q13 in atopic dermatitis families.

Authors:  R Fölster-Holst; H W Moises; L Yang; W Fritsch; J Weissenbach; E Christophers
Journal:  Hum Genet       Date:  1998-02       Impact factor: 4.132

Review 9.  Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders.

Authors:  Marie Lodén
Journal:  Am J Clin Dermatol       Date:  2003       Impact factor: 7.403

10.  The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis.

Authors:  H C Williams; P G Burney; R J Hay; C B Archer; M J Shipley; J J Hunter; E A Bingham; A Y Finlay; A C Pembroke; R A Graham-Brown
Journal:  Br J Dermatol       Date:  1994-09       Impact factor: 9.302

View more
  1 in total

1.  Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis.

Authors:  Michela Campolo; Giovanna Casili; Irene Paterniti; Alessia Filippone; Marika Lanza; Alessio Ardizzone; Sarah A Scuderi; Salvatore Cuzzocrea; Emanuela Esposito
Journal:  Int J Mol Sci       Date:  2020-05-19       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.